| Kindred At Home | |
| 4401 Masthead Street Ne Suite 105, Albuquerque, New Mexico 87109 | |
| (505) 345-3754 | |
| Name | Kindred At Home |
|---|---|
| Location | 4401 Masthead Street Ne Suite 105, Albuquerque, New Mexico |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 327070 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 87001, 87004, 87008, 87034, 87041, 87043, 87048, 87052, 87059, 87072, 87083, 87102, 87104, 87105, 87106, 87107, 87108, 87109, 87110, 87111, 87112, 87113, 87114, 87120, 87121, 87122, 87123, 87124, 87144, 87501, 87502, 87505, 87506, 87507, 87508, 87535, 87540, 87552, 87574 |
| NPI Number | 1295761997 |
| Organization Name | CENTERWELL CERTIFIED HEALTHCARE CORP. |
| Doing Business As | CENTERWELL HOME HEALTH |
| Address | 4401 Masthead St Ne Ste 105, Albuquerque, NM 87109 |
| Phone Number | 505-345-3754 |
News Archive
Pharma IQ is pioneering new compound management discussion platform with launch of the first ever compound management event - Compound Management and Integrity Online event, which will take an innovative form of 11 online session over the course of 5 weeks, beginning 31st of October 2011.
A University of Florida engineer has built a working prototype for a small, portable system that can monitor a person's breathing and heart rate automatically via wireless signal, with no need for cords or plugs. The goal is to make it easy for people to check their own vital signs, and then transmit them in real time to medical personnel through a cell phone or Internet connection, all with little more than a press of a button.
IRIS International, Inc. a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that Iris Molecular Diagnostics (IMD)has been granted Patent No. EP1842226B1 by the European Patent Office (EPO) covering aspects of IMD's NADiA ultra-sensitive protein detection and cell phenotyping platform, which can detect proteins in the femtogram (1 quadrillionth) per milliter range and phenotype single cells.
Maynooth University scientists have identified a protein in the body that may have the potential to prevent the development of obesity-driven diabetes.
› Verified 3 days ago
| Quality Rating: |
News Archive
Pharma IQ is pioneering new compound management discussion platform with launch of the first ever compound management event - Compound Management and Integrity Online event, which will take an innovative form of 11 online session over the course of 5 weeks, beginning 31st of October 2011.
A University of Florida engineer has built a working prototype for a small, portable system that can monitor a person's breathing and heart rate automatically via wireless signal, with no need for cords or plugs. The goal is to make it easy for people to check their own vital signs, and then transmit them in real time to medical personnel through a cell phone or Internet connection, all with little more than a press of a button.
IRIS International, Inc. a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that Iris Molecular Diagnostics (IMD)has been granted Patent No. EP1842226B1 by the European Patent Office (EPO) covering aspects of IMD's NADiA ultra-sensitive protein detection and cell phenotyping platform, which can detect proteins in the femtogram (1 quadrillionth) per milliter range and phenotype single cells.
Maynooth University scientists have identified a protein in the body that may have the potential to prevent the development of obesity-driven diabetes.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 97.8 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.3 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.9 | 99.6 |
| How often the home health team checked patients for depression | 99.3 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 79.6 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 82.8 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 96.3 | 96.4 |
News Archive
Pharma IQ is pioneering new compound management discussion platform with launch of the first ever compound management event - Compound Management and Integrity Online event, which will take an innovative form of 11 online session over the course of 5 weeks, beginning 31st of October 2011.
A University of Florida engineer has built a working prototype for a small, portable system that can monitor a person's breathing and heart rate automatically via wireless signal, with no need for cords or plugs. The goal is to make it easy for people to check their own vital signs, and then transmit them in real time to medical personnel through a cell phone or Internet connection, all with little more than a press of a button.
IRIS International, Inc. a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that Iris Molecular Diagnostics (IMD)has been granted Patent No. EP1842226B1 by the European Patent Office (EPO) covering aspects of IMD's NADiA ultra-sensitive protein detection and cell phenotyping platform, which can detect proteins in the femtogram (1 quadrillionth) per milliter range and phenotype single cells.
Maynooth University scientists have identified a protein in the body that may have the potential to prevent the development of obesity-driven diabetes.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 80.3 | 79.6 |
| How often patients got better at getting in and out of bed | 77.4 | 81.1 |
| How often patients got better at bathing | 85.1 | 82.3 |
| How often patients’ breathing improved | 85.3 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 92.9 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 76.7 | 75 |
| How often home health patients had to be admitted to the hospital | 15.3 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 16.1 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 85.8 | 94 |
News Archive
Pharma IQ is pioneering new compound management discussion platform with launch of the first ever compound management event - Compound Management and Integrity Online event, which will take an innovative form of 11 online session over the course of 5 weeks, beginning 31st of October 2011.
A University of Florida engineer has built a working prototype for a small, portable system that can monitor a person's breathing and heart rate automatically via wireless signal, with no need for cords or plugs. The goal is to make it easy for people to check their own vital signs, and then transmit them in real time to medical personnel through a cell phone or Internet connection, all with little more than a press of a button.
IRIS International, Inc. a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that Iris Molecular Diagnostics (IMD)has been granted Patent No. EP1842226B1 by the European Patent Office (EPO) covering aspects of IMD's NADiA ultra-sensitive protein detection and cell phenotyping platform, which can detect proteins in the femtogram (1 quadrillionth) per milliter range and phenotype single cells.
Maynooth University scientists have identified a protein in the body that may have the potential to prevent the development of obesity-driven diabetes.
› Verified 3 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Pharma IQ is pioneering new compound management discussion platform with launch of the first ever compound management event - Compound Management and Integrity Online event, which will take an innovative form of 11 online session over the course of 5 weeks, beginning 31st of October 2011.
A University of Florida engineer has built a working prototype for a small, portable system that can monitor a person's breathing and heart rate automatically via wireless signal, with no need for cords or plugs. The goal is to make it easy for people to check their own vital signs, and then transmit them in real time to medical personnel through a cell phone or Internet connection, all with little more than a press of a button.
IRIS International, Inc. a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that Iris Molecular Diagnostics (IMD)has been granted Patent No. EP1842226B1 by the European Patent Office (EPO) covering aspects of IMD's NADiA ultra-sensitive protein detection and cell phenotyping platform, which can detect proteins in the femtogram (1 quadrillionth) per milliter range and phenotype single cells.
Maynooth University scientists have identified a protein in the body that may have the potential to prevent the development of obesity-driven diabetes.
› Verified 3 days ago
The patient survey data of Kindred At Home is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 88 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 83 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 84 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 76 | 78 |
News Archive
Pharma IQ is pioneering new compound management discussion platform with launch of the first ever compound management event - Compound Management and Integrity Online event, which will take an innovative form of 11 online session over the course of 5 weeks, beginning 31st of October 2011.
A University of Florida engineer has built a working prototype for a small, portable system that can monitor a person's breathing and heart rate automatically via wireless signal, with no need for cords or plugs. The goal is to make it easy for people to check their own vital signs, and then transmit them in real time to medical personnel through a cell phone or Internet connection, all with little more than a press of a button.
IRIS International, Inc. a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that Iris Molecular Diagnostics (IMD)has been granted Patent No. EP1842226B1 by the European Patent Office (EPO) covering aspects of IMD's NADiA ultra-sensitive protein detection and cell phenotyping platform, which can detect proteins in the femtogram (1 quadrillionth) per milliter range and phenotype single cells.
Maynooth University scientists have identified a protein in the body that may have the potential to prevent the development of obesity-driven diabetes.
› Verified 3 days ago
Presbyterian Home Healthcare Location: 8100 Constitution Place Ne, Suite 400, Albuquerque, New Mexico 87110 Ratings: Phone: (505) 559-6024 | |
Kindred At Home Location: 4401 Masthead Street Ne Suite 105, Albuquerque, New Mexico 87109 Ratings: Phone: (505) 345-3754 | |
Heritage Home Healthcare & Hospice, Inc Location: 3721 Rutledge Road Ne, Unit A, Albuquerque, New Mexico 87109 Ratings: Phone: (505) 232-3300 | |
Advantage Home Care, Inc Dba Corus Home Health Location: 8725 Alameda Park Dr Ne, Albuquerque, New Mexico 87113 Ratings: Phone: (505) 828-0232 | |
Harmony Home Health Services, Llc Location: 5700 Harper Drive Ne, Suite 250, Albuquerque, New Mexico 87109 Ratings: Phone: (505) 828-2273 | |
Alliance Home Health Care, Llc Location: 5981 Jefferson Road Ne, Albuquerque, New Mexico 87109 Ratings: Phone: (505) 884-4080 |